Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Analyst Forecast Pushes Alphabet Shares Toward $365 Target

Robert Sasse by Robert Sasse
December 11, 2025
in AI & Quantum Computing, Analysis, Nasdaq, Tech & Software
0
Alphabet Stock
0
SHARES
34
VIEWS
Share on FacebookShare on Twitter

A prominent Wall Street firm has issued a significant vote of confidence in Alphabet Inc. Piper Sandler raised its price target for the Google parent company to $365 from $330, establishing a new Street-high projection. The upgrade arrives as Alphabet bolsters its artificial intelligence leadership team with the appointment of a new chief technologist for AI infrastructure. Despite these developments, the company’s shares traded marginally lower on Thursday.

Valuation and Competitive Positioning

Even with the recent optimism, Alphabet’s valuation remains compelling relative to its mega-cap technology peers. Based on forward earnings estimates for 2026, the stock trades at a price-to-earnings multiple of approximately 21, positioning it as one of the more reasonably valued members of the so-called “Magnificent Seven.” This valuation context is notable, as evidenced by Oracle’s recent post-market decline of over 11% following its quarterly report. That selloff suggests investors are applying heightened scrutiny to tech sector valuations.

Strategic AI Investments Intensify

The analyst’s bullish outlook is underpinned by Alphabet’s aggressive and structured investments in artificial intelligence. The company has named Amin Vahdat as its new Chief Technologist for AI Infrastructure, placing an experienced expert at the helm of a division expected to account for capital expenditures exceeding $90 billion in 2025. Vahdat’s role will be to ensure the efficiency of these substantial investments—a critical function given that hyperscalers including Google, Microsoft, and Amazon are collectively projected to spend around $400 billion on AI infrastructure.

Should investors sell immediately? Or is it worth buying Alphabet?

In a parallel strategic move, Alphabet has joined the newly formed “Agentic AI Foundation,” an initiative under the Linux Foundation. The coalition, which includes OpenAI, Microsoft, and Amazon Web Services (AWS), aims to establish standards for agentic AI systems. This collaboration could potentially unlock new revenue streams for Google Cloud. Notably, Meta Platforms is absent from this alliance, apparently pursuing a more independent strategy with its “Avocado” model.

Regulatory and Operational Headwinds Persist

The company continues to navigate significant challenges. Reports indicate Alphabet faces a substantial EU antitrust fine by the end of 2025 related to its app store rules. Furthermore, its autonomous vehicle unit, Waymo, has initiated a recall affecting 3,067 vehicles—an operational setback within Alphabet’s “Other Bets” portfolio.

Technical and Long-Term Trajectory

From a chart perspective, Alphabet’s stock is consolidating just below its record highs. A sustained breakout above the $321 level could pave the way toward the new analyst target of $365, with support around $313 having held thus far. Looking further ahead, some market researchers believe Alphabet has a path toward a $5 trillion market capitalization by 2028, driven primarily by the monetization of AI across its core Search and YouTube platforms.

Ad

Alphabet Stock: Buy or Sell?! New Alphabet Analysis from March 25 delivers the answer:

The latest Alphabet figures speak for themselves: Urgent action needed for Alphabet investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Alphabet: Buy or sell? Read more here...

Tags: Alphabet
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Next Post
Oxford Lane Capital Stock

Assessing Oxford Lane Capital's Latest Portfolio Valuation

Vulcan Energy Stock

Vulcan Energy Secures Funding and Site, Pivots to Construction Phase

Prudential Stock

Prudential Financial Unveils $1 Billion Shareholder Return Initiative and Leadership Appointment

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com